| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 34 | 2024 |
| Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study JH Ford, VL Stauffer, P McAllister, S Akkala, M Sexson, DW Ayer, S Wang Quality of Life Research 30, 455-464, 2021 | 8 | 2021 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 7 | 2024 |
| Beta-adrenergic drugs and risk of Parkinson’s disease: A systematic review and meta-analysis A Singh, S Hussain, S Akkala, J Klugarova, A Pokorna, M Klugar, ... Ageing Research Reviews 80, 101670, 2022 | 7 | 2022 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 4 | 2024 |
| Systematic Review and Meta-Analysis Protocol: Beta adrenoreceptor drugs and risk of Parkinson’s disease A Singh, S Hussain, S Akkala, J Klugarová, A Pokorná, M Klugar, ... medRxiv, 2021.05. 19.21257436, 2021 | 1 | 2021 |
| Responder definition thresholds of the Migraine-Specific Quality of Life Questionnaire Version 2.1 domains for use in patients with episodic and chronic migraine R Speck, R Yu, J Ford, D Ayer, S Akkala, K Wyrwich QUALITY OF LIFE RESEARCH 28, S129-S129, 2019 | 1 | 2019 |
| Stem cell banking: an update on current scenario H Deshpande, S Akkala, S Rasquinha, S Karpate | 1 | 2015 |
| Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050 J Yingzhao, C Guo, M Abbasian, M Abbasifard, JH Abbott, A Abdullahi, ... Elsevier, 2024 | | 2024 |
| Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050 Y Jin, C Guo, M Abbasian, M Abbasifard, JH Abbott, A Abdullahi, A Abedi, ... Med, 2024 | | 2024 |
| Efficacy outcomes of treatments for double exposed chronic lymphocytic leukemia/small lymphocytic lymphoma: A systematic literature review. Zuber M, Akkala S, Ahmad A, Villa Zapata L J Clin Oncol 42 (16), 2024 | | 2024 |
| Impact of Pain on Activities of Daily Living in Older Adults: A Cross-Sectional Analysis of Korean Longitudinal Study of Aging (KLoSA) Singh A, Akkala S, Nayak M, Kotlo A, Poondla N, Raza S, Stankovich J, Antony B Geriatrics 9 (3), 65, 2024 | | 2024 |
| Estimating the Cost-effectiveness of Diabetes Mellitus Preventions Program (DPP) Julie Atta, Mzizi NO, Akkala S 12th Annual Global Health Conference. Houston Global Health Collaborative …, 2024 | | 2024 |
| Density and capacity of substance use service providers in Texas. Akkala S, Tang Y, Rodriguez SA, Gallardo KR, McCurdy SA, Wilkerson JM Texas Substance Use Symposium, Austin, TX, February 29-March 1.Poster …, 2024 | | 2024 |
| Protocol for a systematic review of clinical practice guidelines for the management of long COVID Julie Atta, Sreelatha Akkala, Ambrish Singh, Iheyinwa Odum-Nwabueze, Sia ... https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023460901, 2023 | | 2023 |
| Alternative Peer Groups (APGs) in Adolescent Substance Use Disorder Recovery: An Insight into Services and the Need for Robust Infrastructure Akkala S, Mehta U, Pavaskar RN, Wilkerson JM Texas Society for Public Health Education Conference, Austin, TX, October 27-28, 2023 | | 2023 |
